Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-01 Sale | 2025-10-03 4:56 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 362 | $6.296 | $2,279 | 10,046 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:35 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 1,257 | $6.43 | $8,083 | 84,046 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:34 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 234 | $6.43 | $1,505 | 21,425 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:33 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 401 | $6.43 | $2,578 | 27,710 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:32 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 408 | $6.43 | $2,623 | 29,390 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:31 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 325 | $6.43 | $2,090 | 35,856 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:30 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 23 | $6.43 | $148 | 10,408 (Direct) | View |
| 2025-09-03 Sale | 2025-09-04 4:53 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 12 | $6.78 | $81 | 9,463 (Direct) | View |
| 2025-07-29 Sale | 2025-07-30 4:56 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 191 | $4.37 | $835 | 27,223 (Direct) | View |
| 2025-07-22 Sale | 2025-07-23 5:18 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 238 | $4 | $952 | 9,475 (Direct) | View |
| 2025-05-06 Sale | 2025-05-07 5:03 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 236 | $7.12 | $1,680 | 82,503 (Direct) | View |
| 2025-04-23 Sale | 2025-04-24 4:40 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 419 | $6.17 | $2,585 | 28,853 (Direct) | View |
| 2025-04-04 Sale | 2025-04-07 4:59 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 245 | $3.74 | $916 | 82,739 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:27 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 3,445 | $6.29 | $21,669 | 34,314 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:27 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 11,694 | $6.29 | $73,555 | 82,984 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:26 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 3,587 | $6.29 | $22,562 | 29,272 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:24 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 3,548 | $6.29 | $22,317 | 27,414 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:15 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 571 | $6.29 | $3,592 | 9,713 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:13 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 2,793 | $6.29 | $17,568 | 21,047 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:17 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 5,914 | $0.63 | $3,726 | 320,714 (Direct) | View |
| 2025-02-04 Sale | 2025-02-05 4:16 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 4,099 | $0.65 | $2,664 | 1,120,158 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-15 Option Award | 2025-10-16 4:33 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 12,799 | $0 | 22,845 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:32 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 39,682 | $0 | 67,392 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:30 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 43,650 | $0 | 65,075 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:29 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 114,285 | $0 | 198,331 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:28 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 43,650 | $0 | 79,506 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:25 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Macomber Lori EVP, CFO & Treasurer | 43,650 | $0 | 54,316 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 2,800 | $0 | 84,046 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:34 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 612 | $0 | 21,425 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:33 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 888 | $0 | 27,710 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:32 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 945 | $0 | 29,390 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:31 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 945 | $0 | 35,856 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:30 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 46 | $0 | 10,408 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:15 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Su Zhen Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:13 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:12 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:09 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:08 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:07 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:05 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:54 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 29,998 | $0 | 57,758 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:52 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 29,998 | $0 | 52,858 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:51 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 28,749 | $0 | 50,128 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:49 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 2,799 | $0 | 12,150 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:48 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 60,000 | $0 | 134,678 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:46 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 16,749 | $0 | 35,006 (Direct) | View |